Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.11 is 15% above its 5-year average of -1.30, near the high end of its 5-year range (-1.88–-1.05).
4.23% below its 12-month average of -1.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.27.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.11
EARNINGS PER SHARE (EPS) AVG TTM
-1.06
EARNINGS PER SHARE (EPS) AVG 3Y
-1.20
EARNINGS PER SHARE (EPS) AVG 5Y
-1.30
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.23%
CURRENT VS 3Y AVG
+7.11%
CURRENT VS 5Y AVG
+14.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Rapid Micro Biosystems, Inc.
Market Cap
$42.72M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.06
3Y Avg
-1.20
5Y Avg
-1.30
Market Cap
$42.83M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.03
3Y Avg
-1.29
5Y Avg
-1.28
Market Cap
$42.99M
Earnings Per Share (EPS)
-1.98
TTM Avg
-2.34
3Y Avg
-2.17
5Y Avg
-1.92
Market Cap
$42.26M
Earnings Per Share (EPS)
-0.87
TTM Avg
-1.21
3Y Avg
-1.66
5Y Avg
-1.49
Market Cap
$41.95M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
Market Cap
$41.83M
Earnings Per Share (EPS)
-0.65
TTM Avg
-1.58
3Y Avg
-4.60
5Y Avg
-6.89
Market Cap
$44.02M
Earnings Per Share (EPS)
0.69
TTM Avg
-0.78
3Y Avg
-1.53
5Y Avg
-2.71
Market Cap
$44.71M
Earnings Per Share (EPS)
0.90
TTM Avg
-2.83
3Y Avg
-6.22
5Y Avg
-12.54
Market Cap
$44.72M
Earnings Per Share (EPS)
-0.73
TTM Avg
-1.48
3Y Avg
-1.47
5Y Avg
-1.37
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapid Micro Biosystems, Inc. (RPID) | $42.72M | -1.11 | -1.06 | -1.20 | -1.30 |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -1.70 | -1.03 | -1.29 | -1.28 |
| CVRx, Inc. (CVRX)vs › | $42.99M | -1.98 | -2.34 | -2.17 | -1.92 |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | -0.87 | -1.21 | -1.66 | -1.49 |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -1.68 | 0.78 | 0.08 | -0.02 |
| Precipio, Inc. (PRPO)vs › | $41.83M | -0.65 | -1.58 | -4.60 | -6.89 |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 0.69 | -0.78 | -1.53 | -2.71 |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 0.90 | -2.83 | -6.22 | -12.54 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -0.73 | -1.48 | -1.47 | -1.37 |
| Celularity Inc. (CELU)vs › | $45.73M | -2.83 | -3.12 | -4.06 | -22.86 |
Trailing EPS (TTM)
$-1.11
Forward EPS (Est.)
$-0.94
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.05 |
| 2024-12-31 | -1.08 |
| 2023-12-31 | -1.22 |
| 2022-12-31 | -1.43 |
| 2021-12-31 | -1.88 |
| 2020-12-31 | -1.17 |
| 2019-12-31 | -0.53 |
